Cytokinetics
CYTK
£27.18
Share price
-1.15%
Change (1 day)
-34.94%
Change (1 year)
Categories
EPS for Cytokinetics (CYTK)
EPS in 2025 (TTM): -£4.11
According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -£3.98. In 2024 the company made an earnings per share (EPS) of -£3.95 an increase over its 2023 EPS that were of -£4.10.
EPS history for Cytokinetics from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -£4.11 | 3.92% |
| 2024 | -£3.95 | -3.49% |
| 2023 | -£4.10 | 28.24% |
| 2022 | -£3.19 | 50.18% |
| 2021 | -£2.13 | 40.8% |
| 2020 | -£1.51 | |
| 2018 | -£1.47 | -24.12% |
| 2017 | -£1.93 | -776.32% |
| 2016 | £0.29 | -139.18% |
| 2015 | -£0.73 | 125.58% |
| 2014 | -£0.32 | -67.67% |
| 2013 | -£1.00 | -44.58% |
| 2012 | -£1.80 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | -£5.35 | 34.59% | 🇺🇸 USA |
 Trevena TRVN | -£26.12 | 556.71% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -£37.82 | 851.04% | 🇺🇸 USA |
 Amgen AMGN | £8.31 | -308.88% | 🇺🇸 USA |
 Array Technologies ARRY | -£1.39 | -65.03% | 🇺🇸 USA |